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It could be viral but you don’t know, you 
have not diagnosed it: health worker challenges 
in managing non-malaria paediatric fevers 
in the low transmission area of Mbarara District, 
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Abstract 
Background: In 2012, Uganda initiated nationwide deployment of malaria rapid diagnostic tests (RDT) as recom-
mended by national guidelines. Yet growing concerns about RDT non-compliance in various settings have spurred 
calls to deploy RDT as part of enhanced support packages. An understanding of how health workers currently man-
age non-malaria fevers, particularly for children, and challenges faced in this work should also inform efforts.
Methods: A qualitative study was conducted in the low transmission area of Mbarara District (Uganda). In-depth 
interviews with 20 health workers at lower level clinics focused on RDT perceptions, strategies to differentiate non-
malaria paediatric fevers, influences on clinical decisions, desires for additional diagnostics, and any challenges in 
this work. Seven focus group discussions were conducted with caregivers of children under 5 years of age in facility 
catchment areas to elucidate their RDT perceptions, understandings of non-malaria paediatric fevers and treatment 
preferences. Data were extracted into meaning units to inform codes and themes in order to describe response pat-
terns using a latent content analysis approach.
Results: Differential diagnosis strategies included studying fever patterns, taking histories, assessing symptoms, and 
analysing other factors such as a child’s age or home environment. If no alternative cause was found, malaria treat-
ment was reportedly often prescribed despite a negative result. Other reasons for malaria over-treatment stemmed 
from RDT perceptions, system constraints and provider-client interactions. RDT perceptions included mistrust driven 
largely by expectations of false negative results due to low parasite/antigen loads, previous anti-malarial treatment or 
test detection of only one species. System constraints included poor referral systems, working alone without oppor-
tunity to confer on difficult cases, and lacking skills and/or tools for differential diagnosis. Provider-client interactions 
included reported caregiver RDT mistrust, demand for certain drugs and desire to know the ‘exact’ disease cause if 
not malaria. Many health workers expressed uncertainty about how to manage non-malaria paediatric fevers, feared 
doing wrong and patient death, worried caregivers would lose trust, or felt unsatisfied without a clear diagnosis.
Conclusions: Enhanced support is needed to improve RDT adoption at lower level clinics that focuses on empower-
ing providers to successfully manage non-severe, non-malaria paediatric fevers without referral. This includes building 
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Background
Presumptive malaria treatment of all febrile children has 
long been promoted in malaria-endemic African settings 
without adequate diagnostics [1]. In 2010 however, the 
World Health Organization (WHO) revised guidelines 
to recommend parasitological diagnosis of all suspected 
malaria cases and treatment based on test results [2]. 
Uganda subsequently revised national malaria treatment 
guidelines in 2012 and began nationwide deployment of 
malaria rapid diagnostic tests (RDT) in order to achieve 
universal diagnosis goals [3].
This policy shift has great potential to improve rational 
drug use and quality fever management by excluding 
malaria as the fever cause and prompting health workers 
to further assess and treat other conditions [4]. Yet many 
studies indicate continued inappropriate management of 
acute febrile illnesses even after RDT introduction [5–7]. 
Health workers commonly prescribe anti-malarial drugs 
to febrile patients despite a negative test result [6, 7]. In 
studies where these drugs were largely restricted to posi-
tive cases, some research indicates widespread antibiotic 
prescriptions for test-negative patients [8, 9].
Growing concerns about RDT non-compliance have 
spurred calls to deploy RDT with enhanced support 
packages and as part of integrated fever management 
protocols, notably integrated management of childhood 
illness (IMCI) for sick children [10]. This important effort 
should also be grounded in a broad understanding of how 
health workers currently manage non-malaria fevers at 
lower level facilities, their own desires for additional sup-
port or diagnostics, and any perceived challenges in this 
clinical work.
Qualitative research to date has generally focused on 
reasons for malaria over-diagnosis and RDT non-com-
pliance, and has largely been conducted in areas with 
intense malaria transmission [11–18]. One recent study 
in the pre-elimination context of Zanzibar specifically 
investigated how non-malaria fevers are managed in 
peripheral clinics, and found health workers generally 
trust negative RDT results but have difficulty differentiat-
ing viral from bacterial infections [19]. Similar research 
is needed from low- to moderate-transmission areas 
in mainland sub-Saharan Africa where managing non-
malaria fevers is common practice.
This paper explores how non-malaria paediatric fevers 
are managed by health workers at lower level facili-
ties in the low-transmission setting of Mbarara District 
(Uganda), including RDT perceptions, strategies to dif-
ferentiate among non-malaria fevers, influences on 
clinical decisions, desires for additional diagnostics, and 
challenges faced in this work. Caregivers of children 
under 5  years old are similarly interviewed about their 
RDT perceptions and treatment preferences for non-
malaria paediatric fevers to check for consistency or 
disagreement among respondents in order to develop a 
broader understanding of potential barriers to managing 
non-malaria paediatric fevers in this setting.
Methods
Study site
This study was conducted in Mbarara District, which is 
a largely rural farming district situated 270  km south-
west of Kampala. This district is home to nearly 500,000 
people with half the population under 18 years old [20]. 
Malaria transmission peaks in March–May and Septem-
ber-December, and a reduction in malaria transmission 
has occurred in recent years [21]. A recent survey found 
low prevalence (5 %) of malaria infection in young chil-
dren in the southwestern region of Uganda [22].
There are 58 health facilities in the district (49 govern-
ment and 9 private) [23]. The first level of the district 
health system (Health Centre I, or HC-I) includes com-
munity-based services delivered by village health teams. 
The next level includes Health Centre II (HC-II) facilities 
that provide outpatient services, and are generally led by 
an enrolled or registered nurse trained to manage com-
mon diseases and to provide family planning and ante-
natal care services. HC-III facilities are generally led by 
a clinical officer, and are equipped with an outpatient 
clinic, maternity ward and may have functional labora-
tory services [24]. Private drug shops are also an impor-
tant means to obtain medicines by community members 
[25].
Uganda mainly uses Astel™ or CareStart™ for the 
detection of histidine-rich protein 2 (HRP2) from Plas-
modium falciparum [26]. Nationwide RDT deployment 
was initiated in December 2012, and was accompanied 
by basic training in RDT use and integrated malaria man-
agement in most districts. This training targeted health 
workers at all levels, including the private sector [27].
Data collection
A qualitative approach based on in-depth interviews with 
health workers and focus group discussions (FGDs) with 
trust in negative results, reinforcing integrated care initiatives (e.g., integrated management of childhood illness) and 
fostering communities of practice according to the diffusion of innovations theory.
Keywords: Uganda, Child health, Malaria, Fever, Diagnosis, Qualitative, Point-of-care diagnostics
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caregivers of children under 5 years old was used in this 
study. Data collection was carried out during a 3-week 
period in the dry season (July 2014).
Twenty in-depth interviews and seven FGDs were 
conducted with sample sizes determined by topical sat-
uration [28]. Health workers interviewed included 13 
women and seven men. There were four clinical officers, 
one midwife, 11 nurses and four nurse assistants, and 
participants largely worked at lower level public facili-
ties (eight in HC-II and ten in HC-III) except two who 
worked in HC-IV facilities. Each HC-II facility conducted 
malaria diagnosis using RDT while higher level facili-
ties generally had both RDT and microscopy capacity. 
Participant age and work experience ranged from 23 to 
58  years and 1.5 to 30  years, respectively. Seven FGDs 
were also conducted that included caregivers of children 
under 5 years old living in facility catchment areas. FGD 
participants included mothers aged 20–43 years old and 
two grandmothers above 50 years.
For health workers, in-depth interviews each last-
ing 30–60 min were conducted at a purposive sample of 
facilities, primarily targeting lower level, government-
run, health centres (HC-II, -III) dispersed across the two 
health sub-districts that were identified in collaboration 
with the Assistant District Health Officer. In each facility, 
one health worker responsible for outpatient sick child 
consultations was asked to participate in the study. Inter-
views were conducted in English in a private office within 
the facility by the study authors (EWJ, FEK, CM) with one 
research assistant to make up two interview teams, each 
comprised of two people. All interviewers are trained in 
epidemiology and/or pharmacy. One researcher led the 
interview while the other recorded observations and any 
non-verbal communication.
For caregivers, FGDs each lasting 60–90  min were 
conducted in catchment areas of participating facilities 
using convenience-sampling techniques. A purposively 
selected group of caregivers with children under 5 years 
were identified in collaboration with village leaders. 
FGDs included 6 to 12 participants and were led by an 
experienced social scientist fluent in the local language 
(Runyankole) and accompanied by a notetaker to record 
observations. The moderator received a half-day training 
on the study’s purpose, interview goals and topic guide. 
The moderator and study team discussed emerging 
themes from discussions after each FGD.
Interviews were based on a semi-structured topic guide 
that focused on how non-malaria paediatric fevers are 
managed at lower level facilities. For health workers, spe-
cific themes included: RDT perceptions; influences on 
testing and treatment decisions; strategies to differentiate 
non-malaria paediatric fevers; understandings of poten-
tial alternative diagnoses; desires for additional support; 
and, any dilemmas or challenges. For caregivers, the 
topic guide explored: RDT experiences and perceptions; 
understandings of paediatric fever causes; treatment 
preferences for RDT-negative children; and, acceptabil-
ity of withholding anti-malarial drugs. Both topic guides 
were pilot tested and results discussed among the study 
team. These interviews were included in the analysis 
since there were few resulting modifications to study 
tools.
Data management and analysis
All interviews and FGDs were audio recorded and 
complemented with any field notes. Recordings were 
transcribed and translated into English (for FGDs) 
by bilingual research assistants working on a simi-
lar research project in the district. The lead author 
(EWJ) checked interview transcripts for health work-
ers against the recordings to ensure their accuracy, and 
FGD transcripts were separately reviewed and cleaned. 
All transcripts were carefully read multiple times by 
the lead authors (EWJ, FEK) and were separately coded 
using a latent content analysis approach [29]. Data were 
extracted into meaning units that informed an initial 
coding scheme. Preliminary codes were refined by EWJ 
and applied back to the transcripts. These codes were dis-
cussed and revised by EWJ and FEK, and grouped into 
mutually agreed themes to describe response patterns. 
These themes were further refined into a set of final cat-
egories that reflected the study objectives and notable 
‘clusters of influence’ according to the Diffusion of Inno-
vations theory that is further described in later sections. 
Briefly, this theory emerged in the 1960s with Everett 
Rogers seminal work to understand how, why and at what 
rate new ideas or innovations are adopted within a social 
group [30]. Since this time, the diffusion of innovations 
theory has been reviewed, modified and applied across 
different disciplines, including the spread of innovations 
within health care organizations [31–34]. Open Code 
4.01 (University of Umeå, Sweden) was used for data 
analysis [35].
Ethical considerations
Ethical approval was obtained from the WHO Ethi-
cal Review Committee, the Makerere University School 
of Public Health IRB (IRB00011353) and the Uganda 
National Council for Science and Technology (HS 1385). 
Individual, written, informed consent to participate in 
the study and to audio record conversations was obtained 
from all participants. Prior to involvement, participants 
were verbally informed about the research purpose and 
protocols, confidentiality arrangements, and how audio 
recordings would be handled. All personal information 
identifying participants was omitted from transcripts.
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Results
Interviews started by asking health workers about per-
ceived common fever causes among sick children visit-
ing their facility. Malaria, pneumonia, flu, common cold, 
diarrhoea were commonly mentioned in addition to sev-
eral responses of urinary tract infections, viral infections, 
otitis media, typhoid, and anaemia. Caregivers similarly 
responded: malaria, flu, cough, diarrhoea, worms, bad 
food as well as mention of ear infections, pneumonia, 
urine problems, skin wounds, enlarged spleen (ekibaare), 
syphilis, typhoid, measles, chicken pox, and evil spirit 
attacks (mahembe).
Fever differentiation strategies
Most health workers agreed that a negative RDT result 
prompted them to probe further for alternative causes, 
while a positive result was not mentioned as eliciting 
this same clinical decision. Few health workers, how-
ever, spontaneously mentioned IMCI as a classification 
tool for differentiating fevers, although most spoke about 
taking histories and assessing symptoms as main prob-
ing strategies. Symptoms commonly noted as impor-
tant for illness differentiation included diarrhoea, cough 
or breathing problems (as indications of pneumonia) as 
well as skin, ear, eye or urinary infections, anaemia, and 
dehydration. Studying fever patterns was mentioned, 
particularly by clinical officers, as important for differen-
tial diagnosis. Intermittent fevers were noted to indicate 
malaria while persistent fevers could be other infections 
and typhoid may result in a stepladder fever pattern.
“It depends on the duration and their pattern 
because we have the stepladder fever, we have the 
on-and-off, we have the persistent. The persistent is 
mainly due to infection. The fever that is on-and-off 
is malaria. The stepladder that one could be typhoid 
but when you get such history you do an exam and 
you send them for confirmatory diagnostic tests.” 
(Health worker 3)
Some health workers spontaneously mentioned ana-
lysing other factors for fever differentiation, such as 
home environment or mosquito net use. Interviewers 
also explicitly probed for the influence of a child’s age 
or malaria transmission season on testing and treat-
ment practices. Health workers generally reported test-
ing all suspected cases (e.g., fever) no matter the age or 
season, although malaria suspicion seemed lower for 
young infants or in dry seasons. A few health workers 
responded that they did not test young children under 2 
or 4 months old, and these children were either referred 
or not suspected of having malaria.
Another common strategy was to confirm the negative 
RDT result with microscopy if available, or to refer for blood 
smear confirmation at other facilities. One health worker, in 
contrast, mentioned ordering microscopy for RDT-positive 
cases to determine illness severity and parasite load.
“We use [microscopy] when we see that this person has 
malaria clinically, and have tested using RDT and 
it tests negative. So you decide to test with the micro-
scope.” (Health worker 18)
Influences on managing non‑malaria paediatric fevers
Overall, many health workers described prescribing 
malaria treatment despite a negative RDT result if no 
alternative cause was found and microscopy confirmation 
or referral was not possible. Alternative fever causes that 
could prompt different treatment options (notably antibi-
otics or oral rehydration solutions) were suspected pneu-
monia (e.g., cough, difficult breathing) or diarrhoea as well 
as some mentions of eye, ear, skin or urinary infections.
“A child comes with fever when it is due to other ill-
nesses like pneumonia, diarrhoea, so you find most 
of the signs are much related with other conditions 
and not malaria. So we don’t usually consider that 
fever to be malaria. But sometimes if the fever is not 
associated with other signs and symptoms of other 
conditions so there you put a question mark and you 
go ahead and treat [for malaria]” (Health worker 1)
Malaria over-treatment for RDT negative results also 
seemed driven by a combination of RDT perceptions, 
system constraints and provider-client interactions that 
in turn elicited various dilemmas or feelings in health 
workers about managing non-malaria paediatric fevers.
RDT perceptions
Health workers expressed general RDT mistrust that was 
either explicitly mentioned during interviews or implied 
by a stated preference to confirm the negative RDT result 
using microscopy.
“You see many signs and symptoms like fever, head-
ache and so on and yet the results of the RDT show 
otherwise. Me I don’t usually trust the results of the 
RDT.” (Health worker 15)
In many cases RDT doubts were fueled by previous 
experience where multiple testing gave contradictory 
results (e.g., RDT negative but blood smear positive). 
One health worker, in contrast, doubted the RDT positive 
result while two others expressed strong trust in RDT 
results, even over blood smear readings.
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“We have come to realize there is no way I can 
prove that [RDTs] are not working or they are work-
ing because sometimes you test a person and she is 
negative. But clinically you really see that is malaria 
and then usually I wonder there are some cases you 
put on RDTs and they become negative but when 
you put on microscope, positive.” (Health worker 1)
This general RDT mistrust also seemed driven by 
expectations of false negative results in certain situa-
tions, including low parasite/antigen loads, previous 
anti-malarial dose or test detection of only one species. 
Table  1 highlights the various ways these perceptions 
were expressed to interviewers.
Low parasite/antigen loads
First, many health workers explained that an RDT posi-
tive result is difficult to obtain during initial illness 
stages since RDTs may be insensitive to low parasite/
antigen loads. In these cases, malaria treatment for an 
RDT-negative result was generally seen as appropriate 
in order to treat the malaria infection the RDT could 
not yet detect. Some health workers expressed this phe-
nomenon as a parasite ‘incubation period’ or that the 
parasites are ‘hidden’, ‘have not yet matured’ or ‘have not 
yet spread out’ (Table 1). Some health workers reported 
this period could last about 3 days from the start of the 
fever episode. Several caregivers similarly described their 
experience of receiving malaria treatment for their RDT-
negative child because ‘the malaria is not yet in the blood’ 
(FGD 7 participant).
“I think that these RDTs to become positive that 
malaria might have persisted or it might have taken 
like three days. But the malaria of one day cannot be 
positive on an RDT. It can’t.” (Health worker 18)
Previous anti‑malarial dose
Second, many health workers mentioned prescribing 
malaria treatment for an RDT negative result if the child 
had recently taken an anti-malarial dose. There were two 
distinct reasons for this practice. Some respondents sug-
gested a need to complete the treatment course even if 
the patient had no detectable malaria infection.
“Sometimes a patient comes with a history of fever 
and has already taken some medication at home. 
She comes here and she tells you that she has 
already taken four tabs [of malaria treatment] from 
somewhere. So you get a sample from her and you do 
an RDT. The RDT can come negative. But since she 
has already told you she has taken the treatment, 
you give her treatment to finish the course.” (Health 
worker 13)
A few health workers also stated that a positive result 
could be difficult to obtain if an anti-malarial drug was 
already present in a child’s system. One caregiver related 
this experience during the FGD.
“Some of us go to clinics first and we are given medi-
cine without testing. So the malaria parasites hide. 
But somehow when they go to test elsewhere the 
malaria is not detected but the doctor kind of under-
stands this and goes ahead and treats malaria.” 
(FGD 1 participant)
Test detection of only one species
Third, in a few instances, health workers mentioned that 
the RDT detects only one parasite species and malaria 
infection may not be detected if caused by another agent.
“The RDT tests only for one species of malaria. The 
person could be having other types of malaria and 
when you give the treatment, although the result was 
negative, the person responds.” (Health worker 8)
System constraints
Many health workers also mentioned health system con-
straints that fueled malaria over-treatment, notably poor 
referral systems, working alone without opportunity to 
confer on difficult cases, and lacking skills and/or tools 
for differential diagnosis. These interconnected system 
constraints were clearly expressed as follows:
“You can see the result is negative. The child is seri-
ously sick. When you talk of referral, the mother is 
there complaining. Then you are there, and you 
say: ‘Now what? What can I do?’ But if we could be 
equipped well with other things. You can do a test 
and it proves the cause of the sickness or if you have 
other cadres of human resources, they can do it. 
There is no doctor. You are there. You are alone. So 
at least if you are a nurse and you fail on something, 
you can consult a doctor or a nursing officer. There is 
nobody.” (Health worker 8)
Referral was a commonly mentioned challenge and 
many HC-II nurses expressed a desire to refer RDT-neg-
ative cases for microscopy confirmation or doctor’s care 
since they felt unable to manage these cases themselves. 
Yet referral challenges limited this option.
“Yes it is a challenge! Now what do you think we can 
do with those patients that test negative? What do 
you think we can do? And they don’t have any other 
causes of fever. We do what, we refer. Yes you refer. It 
is difficult because you tell them refer but the mother 
has no transport. It’s a problem.” (Health worker 18)
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Several respondents mentioned inadequate skills and/
or tools for differential diagnosis, and these problems 
seemed compounded by working alone without opportu-
nity to confer on difficult cases.
“Other conditions which cause fever, we don’t have 
the test. We just do physical examinations. Some-
times like lymph nodes we know the person has 
a bacterial infection. Yes it is a challenge. But 
sometimes we sit in the village, we forget. We need 
refresher training for the health workers about how 
to manage those conditions.” (Health worker 12)
“Sometimes we have been asking ourselves what 
happens to the RDTs. What brings that? As I have 
told you that I am a nursing assistant. So I start ask-
ing myself what can I do. Maybe I think about if I 
am with a clinical officer but on my own, accord-
ing to how I can manage, if I can’t manage I refer.” 
(Health worker 13)
Inadequate supplies of RDTs and essential medicines 
were also commonly mentioned problems. Interview-
ers specifically probed about other tools that could help 
manage non-malaria fevers. Responses included ther-
mometers, stethoscopes, pulse oximeters, respiratory 
rate counters, urine analysis, weighing scales, typhoid 
and brucella tests, although each item was mentioned 
only once or less than a few times. Importantly, some 
HC-II nurses specifically desired microscopes for malaria 
diagnosis. Caregivers also noted these same system con-
straints, and commonly expressed desires to attend ‘big-
ger hospitals’ or to visit doctors seen as more capable of 
differential diagnosis.
“When you reach the hospital there are many tests 
they can conduct. They could test for malaria, 
typhoid. So if I suspect malaria, the doctor should 
decide what else could be bothering the child.” (FGD 
1 participant)
Provider‑client interactions
The provider-client interaction also influenced the man-
agement of non-malaria paediatric fevers, including 
caregiver RDT mistrust, demand for certain drugs, and 
desire to know the ‘exact’ disease cause if not malaria.
Many health workers perceived caregivers as lacking 
malaria knowledge, although a few noted that caregiv-
ers increasingly understood that all fevers are not due 
to malaria. This was attributed to the remaining stigma 
from previous presumptive treatment policies. Yet, FGDs 
showed a proven awareness among caregivers of other 
fever causes. Most health workers felt that while caregiv-
ers accepted malaria diagnosis, or were even eager for 
testing, there remained some mistrust of negative results. 
This overall perception was also reflected in caregiver 
responses.
“By the way the caregivers like those blood tests 
very much. And when you do it they are contented. 
Although those with fever, they still feel that the test 
was not perfect even if you tell them that there is not 
malaria. But they like it.” (Health worker 15)
Many health workers also complained that caregiv-
ers demanded malaria treatment and felt health work-
ers must treat the sick child. Similarly, most caregivers 
said they wanted to receive treatment to cure the child’s 
sickness. Some would demand malaria treatment if they 
strongly felt that was the fever cause, although others 
talked about accepting the result and following the clini-
cal decision. In general, caregivers wanted to know the 
‘exact’ disease cause if not malaria.
“So some parents go ahead and ask for anti-malar-
ial drugs. Some hospitals give into the parents who 
insist on getting the drugs.” (FGD 7 participant)
“My thinking would be that if they don’t detect 
malaria then they should be able to detect any other 
diseases. If they don’t say anything else I would go to 
another hospital with testing machines and get to 
know what the child is suffering from.” (FGD 2 par-
ticipant)
Dilemmas and feelings
The challenges described above elicited various dilemmas 
or feelings about managing non-malaria paediatric fevers. 
Many health workers expressed uncertainty about how to 
manage non-malaria fevers; feared doing wrong, loss to 
follow-up or patient death; worried caregivers would lose 
trust; or, felt unsatisfied without a clear diagnosis.
Some health workers seemed unsure about how to 
manage non-malaria fevers, which was either explicitly 
mentioned during interviews or implied by asking inter-
viewers for guidance.
“Maybe I don’t understand very well those RDTs 
because sometimes you see someone who is really 
sick. But you test the RDT and it is negative. But 
when you give anti-malarial treatment that patient 
improves and becomes okay. I don’t know what 
advice you can give us on such patients. Should we 
continue giving them anti-malarials or we refer 
them for microscopy?” (Health worker 12)
Some also expressed a desire to consult with doc-
tors given uncertainty about managing RDT-negative 
cases. Many caregivers similarly expressed greater trust 
Page 9 of 13Johansson et al. Malar J  (2016) 15:197 
in doctors to manage non-malaria fevers, as previously 
described.
“What I know is that if it’s a more qualified doctor, 
he checks ears, urine and you find maybe the ear has 
an infection and you didn’t know.” (FGD 5 partici-
pant)
Some health workers also feared doing wrong, patient 
loss to follow-up or patient death, which was clearly 
expressed as follows:
“We know malaria is a killer. It actually kills more 
people than accidents. So if you left this child and the 
child went back home, especially those young ones 
below five years, you are not sure whether the par-
ents are going to continue to both assess and monitor 
the status of this child. So in case you miss out, we 
fear maybe this child is going to die before they come 
back. So you would rather give treatment than leave 
this child to go home because some of them come 
from very far. Others do not even have money maybe 
to rush to the nearest clinic in case things happen 
when it is late. So you know, you put all those things 
into consideration.” (Health worker 10)
Several health workers also worried that caregivers 
would lose trust in their services, particularly if clients 
strongly believed the RDT-negative patient had malaria 
and there was no alternative diagnosis. Again, caregivers 
expressed less trust in peripheral clinics to manage non-
malaria fevers underscoring such concerns.
“[Clients] lose trust in you because you’ve told them 
it’s not the disease when they know it’s the disease.” 
(Health worker 20)
“These hospitals to me they are good because they 
have skilled professionals, sometimes when you go 
to a nurse they may not detect the disease.” (FGD 1 
participant)
A few health workers also felt unsatisfied without a 
clear diagnosis, desired to do a better job, and expressed 
dissatisfaction to ‘just blindly treat to see what will come 
out’ (Health worker 15).
“Sometimes when somebody has fever and the RDT 
is negative, and they don’t have pneumonia and 
they just have fever, it is quite challenging because 
we don’t know the cause of the fever. You could think 
it could be viral but you don’t know, you have not 
diagnosed it. So we just give antipyretics. But inside 
you, you are not satisfied. You feel you would have 
done better but you can’t. You don’t have anyway 
how to do it.” (Health worker 5)
Many caregivers shared this desire to know the ‘exact 
disease’ causing the child’s illness.
“You want to make sure you know the exact disease. 
It is like the reason why you take the child to hospi-
tal is to know the exact disease. Because one may as 
well go to the drug shop to buy drugs.” (FGD 5 par-
ticipant)
Health workers generally responded to these dilemmas 
by justifying their clinical decisions, and by noting that 
RDT-negative patients often improve on malaria treat-
ment. Interviewers also asked about the potential down-
sides of malaria over-treatment. Several health workers 
noted increasing drug resistance and incorrectly treating 
other diseases, while a few mentioned wasting resources 
and burdening a child’s body with drugs to eliminate. 
One health worker said there were no downsides while a 
few were unsure how to respond.
Discussion
Study findings indicate that malaria over-treatment for 
RDT-negative results may occur in this low-transmission 
setting if no alternative fever cause is identified. RDT 
non-compliance seemed further driven by a combina-
tion of RDT perceptions, provider-client interactions and 
system constraints that must be addressed to improve 
rational drug use and quality fever management at lower 
level clinics in Mbarara District, Uganda.
Importantly, these constraints reflect long-established 
clusters of influence on the spread of new innovations 
or practices according to the Diffusion of Innovations 
theory [30–34], which was recently adapted to the RDT 
experience in sub-Saharan Africa [13].
RDT perceptions included a general RDT mistrust 
among health workers and caregivers, which has been 
described in other settings [11, 13–18]. This mistrust 
developed in part from provider experiences with contra-
dictory results between RDT and blood smear readings, 
and also from perceptions that a positive result is difficult 
to obtain for certain reasons: low parasite/antigen loads, 
previous anti-malarial treatment and test detection of 
only one species. Many health workers raised concerns 
about RDT insensitivities to low antigen concentrations, 
which is more likely to occur at early illness stages [36]. 
Many health workers also discussed RDT insensitivities 
if a child recently took an anti-malarial dose, although 
current evidence does not support this assertion. Others 
desired to complete the treatment dose despite a negative 
result so as not to create resistance ‘in a child’, but such 
concerns are unwarranted if malaria parasites are not 
present [37]. A few health workers mentioned that RDTs 
could not detect malaria if the infection is caused by a 
species other than P. falciparum.
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These findings show a proven awareness of potential 
problems with RDT malaria detection, such as for low 
parasitaemias or to detect certain parasite species [36], 
and legitimate concerns regarding anti-malarial drug 
resistance [37]. Yet this awareness has been miscon-
strued to inappropriately justify RDT non-compliance, 
and to support a general preference to diagnose malaria 
using routine microscopy or to confirm RDT negative 
results with blood smears. This preference is reinforced 
by national guidelines that promote microscopy as the 
‘gold standard’ for malaria diagnosis in Uganda [3]. It may 
also reflect an underlying desire to continue presumptive 
treatment practices, a long-standing policy that is gener-
ally easier for health workers to implement.
Yet, current evidence shows RDTs are sufficient to 
clinically manage suspected cases in low-transmission 
settings with equal or better performance than routine 
microscopy [38], and low quality routine microscopy for 
malaria has been previously documented [39]. Moreover, 
these understandings do not excuse a lack of probing for 
other fever causes, particularly for patients with early ill-
ness symptoms where some health workers seemed to 
expect false negative results up to 3 days after fever onset. 
Such practices could unnecessarily delay appropriate 
fever management with potentially fatal consequences 
[40].
The Diffusion of Innovations literature suggests that 
innovation perceptions may explain a large part of the 
variance in the adoption of new practices [30, 34], and 
five innovation perceptions are most influential for suc-
cessful uptake: benefit, compatibility, simplicity, trialabil-
ity, and observability.
First, users need to see a relative benefit to the status 
quo if RDTs are adopted, which includes reducing any 
perceived risks in employing the new innovation or prac-
tice. While most health workers understood the advan-
tages of malaria diagnosis and caregivers seemed eager 
for testing, most respondents perceived inherent ‘risks’ 
in the new practice of managing RDT-negative patients—
notably missing a malaria diagnosis—that may greatly 
reduce any perceived benefits. This perception of miss-
ing a malaria diagnosis as ‘risky’ is consistent with other 
research [12]. These perceived risks could be addressed 
through messaging that focuses on the reliability of RDT-
negative results [38], the demonstrated safety of with-
holding anti-malarial treatment [41], and the deliberate 
over-treatment built into the IMCI algorithm for other 
fatal febrile illnesses (e.g., bacterial pneumonias, measles, 
diarrhoeal diseases) in order to specifically avoid severe 
consequences in patients [1]. This could help build trust 
in negative results, and reduce perceived risks in manag-
ing non-malaria paediatric fevers if RDT and IMCI are 
correctly implemented together.
Second, RDT implementation needs to be compat-
ible with current clinical practice. In this study, however, 
most health workers did not find their current training or 
available tools compatible with the new practice of man-
aging RDT-negative patients. Third, simple technologies 
are often more readily adopted than complex ones. While 
RDTs are simple to use, RDT-negative patients were gen-
erally perceived as complicated to manage. Finally, trial-
ability (having a trial or testing period) and observability 
(watching others use the innovation or employ the new 
practice) also aids adoption. Trialability and observabil-
ity, in particular, are especially important for adopting 
‘risky’ practices in order to give users space to experiment 
with the new practice and to understand how others 
have incorporated it into their own work. This provides 
critical, early opportunities to share experiences, answer 
questions, give feedback, address concerns, adapt the 
new practice to routine work, and build confidence that 
others are working in a similar manner [34].
Provider-client interactions emerged as factors influ-
encing management of non-malaria paediatric fevers, 
which have been highlighted elsewhere [16, 18]. Many 
health workers perceived clients as lacking malaria 
knowledge and demanding certain medicines. Yet these 
perceptions were not necessarily supported by FGD find-
ings. Overall, caregivers had a proven awareness of other 
potential fever causes in children. While some mistrusted 
RDTs and might demand anti-malarial medicines, many 
also seemed willing to accept a negative test result but 
desired an alternative diagnosis to understand their 
child’s sickness. To this end, many caregivers preferred 
visiting doctors or higher level facilities, seen as better 
equipped to identify and treat the exact disease cause.
Indeed, the Diffusion of Innovations theory high-
lights user characteristics as another sphere of influence 
on innovation adoption, which in this context includes 
both providers and clients. Some authors have catego-
rized users as ‘innovators’, ‘early adopters’, ‘early majority’, 
‘late majority’, and ‘laggards’, and these categorizations 
may also pertain to adopters in service organizations 
[30, 34]. Early adopters may be seen as opinion leaders 
characterized as professionally respected and resource-
ful. Evidence points to the critical role of opinion leaders 
in promoting innovation adoption by shaping peer opin-
ion [30–34]. In this district, some clinical officers could 
naturally fit that role but greater investments would be 
needed to build up this network, and to subsequently 
connect such ‘opinion leaders’ with other health work-
ers in the district. Clinical officers seemed more knowl-
edgeable than lower health worker cadres regarding 
paediatric fever causes and their management, which 
was a perception shared by most caregivers too. In fact, 
both nurses and caregivers interviewed expressed a clear 
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desire to consult with doctors in order to manage non-
malaria paediatric fevers.
Moreover, evidence suggests that organizations that 
foster informal exchanges among users may experi-
ence faster rates of practice adoption [30–34], and some 
research has also demonstrated improved health out-
comes by facilitating such interactions [42]. Along these 
lines, recent studies have shown improved RDT compli-
ance using interactive training programmes or daily SMS 
reminders that essentially form a basis for improved com-
munication networks and connectedness among adop-
ters [43, 44]. Other researchers have also recommended 
establishing communities of practice, Balint groups or 
peer-learning networks to increase problem-solving and 
mentorship opportunities to improve RDT compliance 
[13]. One additional intervention could include providing 
airtime to nurses at lower level clinics to facilitate real-
time consultations with opinion leaders on difficult cases, 
such as RDT-negative patients.
Clients are also ‘users’ in this context and play a role 
in determining care-seeking strategies and shaping the 
clinical encounter [45]. Community opinion leaders 
are therefore needed to help raise awareness about new 
clinical practices and build community trust in negative 
results. To date, community sensitization to new clini-
cal practices in this district has largely relied on health 
worker counselling of patients, despite their limited 
time. While there is a need to strengthen health worker 
counselling skills, FGD findings also suggest that health 
workers may not be suitable opinion leaders within com-
munities, given some negative perceptions expressed by 
caregivers.
System constraints included poor referral systems, 
working alone without opportunity to confer on difficult 
cases, and lacking skills and/or tools for differential diag-
nosis, which are well-known issues in Uganda [46]. Few 
health workers specifically mentioned using IMCI guide-
lines to differentiate among fever causes, which suggests 
a lack of awareness of the primary tool available to clas-
sify non-malaria fevers. Some health workers referred 
to aspects of this tool but none described employing it 
consistently or even correctly in their practice, and poor 
IMCI implementation has previously been shown in 
Uganda and other settings [47, 48].
It is critical that lower level health workers feel 
empowered to manage non-severe, non-malaria paedi-
atric fever cases without referral, which is the oppo-
site of study findings. There is general consensus about 
the need to deploy RDT as part of integrated fever 
management protocols, notably IMCI for sick chil-
dren [10]. IMCI has been shown to improve quality of 
care for common causes of child morbidity and mor-
tality (e.g., malaria, pneumonia, diarrhoea, measles, 
malnutrition, and ear infections), which often include 
fever as a presenting complaint [49]. There are also 
ongoing initiatives to strengthen the IMCI algorithm 
based on recent etiology studies [50, 51], and in recog-
nition of its poor implementation to date [48]. Effec-
tive implementation of IMCI and RDT together could 
help reduce both anti-malarial and antibiotic over-
treatment associated with RDT-negative results shown 
in other studies [5–9], and suggested by findings for 
this district. Moreover, integrated community case 
management (iCCM) using a simplified IMCI algo-
rithm and RDT has been successfully implemented by 
community health workers and drug shop attendants 
in research studies [52, 53]. Yet, if these pilot stud-
ies are more broadly implemented, these community 
volunteers would be supervised by lower level health 
workers that remarkably lack similar training in inte-
grated care, as suggested in this study.
This lack of IMCI skills to manage non-malaria fevers 
is further compounded by inadequate tools or other 
diagnostics to differentiate fevers, poor referral systems 
and feelings of working alone without opportunities to 
consult on difficult cases, which have been discussed 
elsewhere [54]. Developing communities of practice and 
fostering exchanges among health workers, as previously 
described, could potentially reduce feelings of work-
ing alone without support, reduce the desire to refer 
non-severe cases, build trust in nurses ability to handle 
non-malaria fevers, and satisfy caregiver desire to attend 
bigger hospitals by better linking doctors to peripheral 
clinics. Nevertheless, current findings suggest that some 
over-treatment of dangerous illnesses will remain the 
norm in settings with weak health systems where provid-
ers fear a child may not return if symptoms worsen, and 
are unable to refer them for further testing and medical 
care.
Methodological considerations
The qualitative design was chosen to understand how 
health workers manage non-malaria paediatric fevers 
at lower level clinics and to elucidate reasons for such 
practices, but findings reflect only stated rather than 
observed actions. These stated preferences could reflect 
desires to please interviewers [28]. Yet, triangulation of 
data collected across different interview teams, among 
different health worker cadres and with FGDs, indicates 
broad consistency in information derived from vari-
ous respondents. The geographical spread of interviews 
across numerous lower level clinics in the district pro-
vides a good indication of how non-malaria fevers are 
reportedly managed in this setting, but is not statistically 
representative. External validity of study conclusions 
is strengthened by linking to similar findings in other 
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settings, as well as to theoretical constructs that under-
pin reported phenomena, notably the Diffusion of Inno-
vations theory [28]. Finally, this paper reflects reported 
practices in managing non-malaria paediatric fevers 
about 1.5  years after RDT initiation in this district, and 
may be considered an early assessment that highlights 
perceptions and practices that need to be addressed 
going forward.
Conclusions
Study findings indicate that malaria over-treatment for 
RDT-negative results reportedly occurs in this setting if 
no alternative fever cause is found, and RDT non-compli-
ance is further driven by a combination of RDT percep-
tions, system constraints and patient-client interactions. 
Enhanced support is needed to improve RDT compliance 
at lower level clinics that empowers health workers to 
successfully manage non-severe, non-malaria, paediat-
ric fevers without referral. This includes building trust in 
negative results, reinforcing skills in integrated fever care, 
and facilitating Communities of Practice according to the 
Diffusion of Innovations theory. Such interventions could 
not only improve RDT compliance, rational drug use and 
quality fever care, but also strengthen overall health sys-
tems with RDT as the entry point.
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